Pooja Dewan

Dr. Pooja Dewan is an Honorary Research Fellow at the School of Cardiovascular & Metabolic Health, University of Glasgow. Her research focuses on heart failure pathophysiology, therapeutic interventions, and comorbidity management. She has contributed to landmark trials such as PARADIGM-HF, DAPA-HF, and VICTORIA, analyzing treatments like sacubitril/valsartan, dapagliflozin, and mineralocorticoid receptor antagonists. Her work emphasizes frailty assessment, COPD-HF interactions, and outcomes in low- and middle-income countries.

Key areas of research include:

• Pharmacological therapies in heart failure with reduced (HFrEF) and preserved (HFpEF) ejection fraction
• Multimorbidity burden and comorbidity management strategies
• Biomarker-driven treatment optimization (e.g., cGMP/BNP ratios)
• Geriatric aspects of heart failure care
• Global health disparities in cardiovascular outcomes

Publications (2019-2024) highlight her expertise in clinical trial analysis, subgroup efficacy evaluation, and translational research bridging basic science and clinical practice.